Back

Targeting aldosterone: what ambulatory blood pressure monitoring studies tell us about aldosterone synthase inhibition

30 August 2026 (12:56 - 13:06)
Organised by: Logo
Congress Presentation Part of: 24-hour blood pressure burden: aldosterone, cardiorenal risk, and the next generation of blood pressure control Renin-Angiotensin System Open Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Gianfranco Parati

University of Milan Bicocca, Milan (Italy)

5 More presentations in this session

Presentation thumbnail
Welcome, introduction, program framing, review of objectives
Professor G. Parati (Milan, IT)
Video
Presentation thumbnail
Aldosterone and the 24-hour blood pressure burden
Professor R. Cifkova (Prague, CZ)
Video
Presentation thumbnail
Ambulatory blood pressure monitoring‑detected 24‑hour blood pressure phenotypes in resistant hypertension
Associate Professor G. Bilo (Milan, IT)
Video
Presentation thumbnail
From 24‑hour blood pressure to cardiorenal outcomes and future directions
Doctor P. Taub (La Jolla, US)
Slides Video
Presentation thumbnail
24-hour blood pressure burden: aldosterone, cardiorenal risk, and the next generation of blood pressure control - Q&A
Video

Access the full session

Session thumbnail
24-hour blood pressure burden: aldosterone, cardiorenal risk, and the next generation of blood pressure control
Video

The Event

Event poster

ESC Congress 2026

30 August 2026 12:56 CET
You may be interested in
thumbnail
Congress Presentation
A safety and pharmacodynamic study of the highly selective aldosterone synthase inhibitor PB6440 in the cynomolgus monkey
26 August 2022
thumbnail
Congress Presentation
24-hour ambulatory blood pressure monitoring (ABPM)
18 April 2023
thumbnail
Webinar
Nonsteroidal MRAs and heart failure: interpretation and impact on practice - which patients should be receiving MRAs?
21 July 2025
thumbnail
Congress Presentation
High prevalence of aldosterone dysregulation in hypertensive adults tested for aldosterone and renin levels
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources